Emerging Immunotherapy Approaches for Treating Prostate Cancer

por Meng, Lingbin, Yang, Yuanquan, Mortazavi, Amir, Zhang, Jingsong
Publicado 2023

Low grade papillary transitional cell carcinoma pelvic recurrence masquerading as high grade invasive carcinoma, ten years after radical cystectomy

por Dangle, Pankaj P, Wang, Wenle Paul, Mayerson, Joel, Mortazavi, Amir, Monk, Paul
Publicado 2008

Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report

por Johnson, Kai, Issa, Majd, Parikh, Anish, Monk, Paul, Yin, Ming, Mortazavi, Amir, Yang, Yuanquan
Publicado 2021

Effect of Enfortumab Vedotin Dose Adjustment on Efficacy in Metastatic Urothelial Carcinoma: A Retrospective Single-Center Experience 

por Clennon, Anna, Hinkley, Megan, Nymberg, Kristen, Ledbetter, Lauren, Handley, Demond, McLaughlin, Eric, Mortazavi, Amir, Collier, Katharine A
Publicado 2023

Periodically rotated overlapping parallel lines with enhanced reconstruction acquisition to improve motion-induced artifacts in bladder cancer imaging: Initial findings

por Nguyen, Huyen Thanh, Shah, Zarine Ketul, Mortazavi, Amir, Pohar, Kamal S., Wei, Lai, Zynger, Debra Lyn, Knopp, Michael Vinzenz
Publicado 2019

Quantitative Assessment of Heterogeneity in Bladder Tumor MRI Diffusivity: Can Response be Predicted Prior to Neoadjuvant Chemotherapy?

por Nguyen, Huyen T., Mortazavi, Amir, Pohar, Kamal S., Zynger, Debra L., Wei, Lai, Shah, Zarine K., Jia, Guang, Knopp, Michael V.
Publicado 2017

Comparative effectiveness of surgery versus external beam radiation with/without brachytherapy in high‐risk localized prostate cancer

por Yin, Ming, Zhao, Jing, Monk, Paul, Martin, Douglas, Folefac, Edmund, Joshi, Monika, Jin, Ning, Mortazavi, Amir, Verschraegen, Claire, Clinton, Steven
Publicado 2019

Population Pharmacokinetic Analysis from First-in-Human Data for HDAC Inhibitor, REC-2282 (AR-42), in Patients with Solid Tumors and Hematologic Malignancies: A Case Study for Eval...

por Liva, Sophia, Chen, Min, Mortazavi, Amir, Walker, Alison, Wang, Jiang, Dittmar, Kristin, Hofmeister, Craig, Coss, Christopher C., Phelps, Mitch A.
Publicado 2021

Alterations of DNA damage response genes correlate with response and overall survival in anti‐PD‐1/PD‐L1‐treated advanced urothelial cancer

por Joshi, Monika, Grivas, Petros, Mortazavi, Amir, Monk, Paul, Clinton, Steven K., Sue‐Ann Woo, Michele, Holder, Sheldon L., Drabick, Joseph J., Yin, Ming
Publicado 2020

Increasing the complexity of chromatin: functionally distinct roles for replication-dependent histone H2A isoforms in cell proliferation and carcinogenesis

por Singh, Rajbir, Mortazavi, Amir, Telu, Kelly H., Nagarajan, Prabakaran, Lucas, David M., Thomas-Ahner, Jennifer M., Clinton, Steven K., Byrd, John C., Freitas, Michael A., Parthun, Mark R.
Publicado 2013

A Phase I Study of High-Dose Interleukin-2 With Sorafenib in Patients With Metastatic Renal Cell Carcinoma and Melanoma

por Monk, Paul, Lam, Elaine, Mortazavi, Amir, Kendra, Kari, Lesinski, Gregory B., Mace, Thomas A., Geyer, Susan, Carson, William E., Tahiri, Sanaa, Bhinder, Arvinder, Clinton, Steven K., Olencki, Thomas
Publicado 2014

Proteomic profiling identifies specific histone species associated with leukemic and cancer cells

por Singh, Rajbir, Harshman, Sean W., Ruppert, Amy S., Mortazavi, Amir, Lucas, David M., Thomas-Ahner, Jennifer M., Clinton, Steven K., Byrd, John C., Freitas, Michael A., Parthun, Mark R.
Publicado 2015

Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC)

por Monk, Paul, Liu, Glenn, Stadler, Walter M., Geyer, Susan, Huang, Ying, Wright, John, Villalona-Calero, Miguel, Wade, James, Szmulewitz, Russell, Gupta, Shilpa, Mortazavi, Amir, Dreicer, Robert, Pili, Roberto, Dawson, Nancy, George, Saby, Garcia, Jorge A.
Publicado 2018

Effects of a lifestyle intervention on body composition in prostate cancer patients on androgen deprivation therapy

por Chaplow, Zachary L., Focht, Brian C., Lucas, Alexander R., Grainger, Elizabeth, Simpson, Christina, Buell, Jackie, Fairman, Ciaran M., Thomas-Ahner, Jennifer M., Bowman, Jessica, DeScenza, Victoria R., Monk, J. Paul, Mortazavi, Amir, Clinton, Steven K.
Publicado 2020

Early phase clinical studies of AR‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas

por Welling, D. Bradley, Collier, Katharine A., Burns, Sarah S., Oblinger, Janet L., Shu, Edina, Miles‐Markley, Beth A., Hofmeister, Craig C., Makary, Mina S., Slone, H. Wayne, Blakeley, Jaishri O., Mansouri, S. Alireza, Neff, Brian A., Jackler, Robert K., Mortazavi, Amir, Chang, Long‐Sheng
Publicado 2021

(18)F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab

por Lim, Ilhan, Lindenberg, Maria Liza, Mena, Esther, Verdini, Nicholas, Shih, Joanna H., Mayfield, Christian, Thompson, Ryan, Lin, Jeffrey, Vega, Andy, Mallek, Marissa, Cadena, Jacqueline, Diaz, Carlos, Mortazavi, Amir, Knopp, Michael, Wright, Chadwick, Stein, Mark, Pal, Sumanta, Choyke, Peter L., Apolo, Andrea B.
Publicado 2019

Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study

por Martinez Chanza, Nieves, Xie, Wanling, Issa, Majd, Dzimitrowicz, Hannah, Tripathi, Abhishek, Beuselinck, Benoit, Lam, Elaine, Zakharia, Yousef, Mckay, Rana, Shah, Sumit, Mortazavi, Amir, R. Harrison, Michael, Sideris, Spyridon, Kaymakcalan, Marina D, Abou Alaiwi, Sarah, Nassar, Amin H, Nuzzo, Pier Vitale, Hamid, Anis, K Choueiri, Toni, C Harshman, Lauren
Publicado 2020

Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes

por Grivas, Petros, Mortazavi, Amir, Picus, Joel, Hahn, Noah M., Milowsky, Matthew I., Hart, Lowell L., Alva, Ajjai, Bellmunt, Joaquim, Pal, Sumanta K., Bambury, Richard M., O’Donnell, Peter H., Gupta, Sumati, Guancial, Elizabeth A., Sonpavde, Guru P., Faltaos, Demiana, Potvin, Diane, Christensen, James G., Chao, Richard C., Rosenberg, Jonathan E.
Publicado 2018

A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum‐resistant metastatic urothelial cancer

por Zhang, Tian, Harrison, Michael R., O'Donnell, Peter H., Alva, Ajjai S., Hahn, Noah M., Appleman, Leonard J., Cetnar, Jeremy, Burke, John M., Fleming, Mark T., Milowsky, Matthew I., Mortazavi, Amir, Shore, Neal, Sonpavde, Guru P., Schmidt, Emmett V., Bitman, Bojena, Munugalavadla, Veerendra, Izumi, Raquel, Patel, Priti, Staats, Janet, Chan, Cliburn, Weinhold, Kent J., George, Daniel J.
Publicado 2020

Analytic validation and real-time clinical application of an amplicon-based targeted gene panel for advanced cancer

por Wing, Michele R., Reeser, Julie W., Smith, Amy M., Reeder, Matthew, Martin, Dorrelyn, Jewell, Benjamin M., Datta, Jharna, Miya, Jharna, Monk, J. Paul, Mortazavi, Amir, Otterson, Gregory A., Goldberg, Richard M., VanDeusen, Jeffrey B., Cole, Sharon, Dittmar, Kristin, Jaiswal, Sunny, Kinzie, Matthew, Waikhom, Suraj, Freud, Aharon G., Zhou, Xiao-Ping, Chen, Wei, Bhatt, Darshna, Roychowdhury, Sameek
Publicado 2017